| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83521 |
PAMAM树状大分子DOTA缀合物 PAMAM–DOTA |
160 |
h |
2024-12-19 |
| 83522 |
ALD-tetra-EG-Osu的介绍 |
192 |
zyl |
2024-12-19 |
| 83523 |
SSTR2靶向肽Tyr(3)-奥曲肽(tate) |
297 |
h |
2024-12-19 |
| 83524 |
DOTA-D-Phe(1)-Tyr(3)-Octreotide |
153 |
h |
2024-12-19 |
| 83525 |
cas:55750-63-5，Mal-heptanoic NHS ester |
185 |
zyl |
2024-12-19 |
| 83526 |
DOTA-Fab-PEG24-EGF DOTA-PEG修饰曲妥珠单抗Fab片段偶联表皮生长因子 |
153 |
h |
2024-12-19 |
| 83527 |
cas:663599-10-8，DMAC-SPP |
159 |
zyl |
2024-12-19 |
| 83528 |
多甲基化的1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)配体 |
202 |
h |
2024-12-19 |
| 83529 |
PEG-pGlu(DOTA)8-LA4 |
87 |
h |
2024-12-19 |
| 83530 |
cas:937025-17-7，2,5-Dioxopyrrolidin-1-yl 2-oxo-6,9,12,15-tetraoxa-3-thiaoctadecan-18-oate |
178 |
zyl |
2024-12-19 |
| 83531 |
DOTA-Hyd-TRP PET示踪剂 |
154 |
h |
2024-12-19 |
| 83532 |
Ga-DOTATOC Ga-DOTA-D-Phe-Tyr-奥曲肽 |
226 |
h |
2024-12-19 |
| 83533 |
cas:1226371-65-8，N-(2-(2,5-Dimethylphenoxy)ethyl)-4-formylbenzamide |
125 |
zyl |
2024-12-19 |
| 83534 |
DOTA-ALN DOTA-阿仑膦酸盐 |
127 |
h |
2024-12-19 |
| 83535 |
氨氯地平DOTA偶联物 DOTA-Amlodipine |
246 |
h |
2024-12-19 |
| 83536 |
cas:906564-59-8，Propargyl-C2-NHS ester |
140 |
zyl |
2024-12-19 |
| 83537 |
DOTA-Gp2-EGFR DOTA螯合剂标记结合表皮生长因子受体EGFR靶向Gp2 |
123 |
h |
2024-12-19 |
| 83538 |
cas:894095-98-8，β-D-glucuronide-pNP-carbonate |
127 |
zyl |
2024-12-19 |
| 83539 |
DOTA结合肽功能化金纳米粒子 |
145 |
h |
2024-12-19 |
| 83540 |
90Y-DOTA-Bn 钇-90-DOTA-铃蟾肽 |
213 |
h |
2024-12-19 |
| 83541 |
cas:85916-13-8，NH-bis(C1-Boc)，亚氨基二乙酸二异丁酯 |
172 |
zyl |
2024-12-19 |
| 83542 |
Anti-CD19 (clone huB4)-Mc-MMAF-ADC分子 |
96 |
zyl |
2024-12-19 |
| 83543 |
Boc-Val-Cit-PAB-PNP cas:870487-10-8 |
110 |
zyl |
2024-12-19 |
| 83544 |
cas:2353409-70-6 MMAF-methyl ester |
222 |
zyl |
2024-12-19 |
| 83545 |
DOTA-ipilimumab 螯合剂DOTA缀合单克隆抗体ipilimumab |
145 |
h |
2024-12-19 |
| 83546 |
双功能单膦酸Ln-DOTA衍生物 |
153 |
h |
2024-12-19 |
| 83547 |
Cu-DOTA-阿伦膦酸盐 Cu-DOTA-alendronate |
142 |
h |
2024-12-19 |
| 83548 |
Mc-3377的介绍 |
122 |
zyl |
2024-12-19 |
| 83549 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAF的介绍 |
117 |
zyl |
2024-12-19 |
| 83550 |
(DOTA)n-PAMAM-[尼妥珠单抗-F(ab’)2]的缀合物 |
127 |
h |
2024-12-19 |
| 83551 |
cas:2055041-39-7 Mal-PEG4-Val-Cit-PAB-OH |
159 |
zyl |
2024-12-19 |
| 83552 |
DBCO-PEG3-Val-Cit-PAB-PNP的介绍 |
178 |
zyl |
2024-12-19 |
| 83553 |
(DOTA)5-十氢赖氨酸(DOTA)5-decalysine |
182 |
h |
2024-12-19 |
| 83554 |
DOTA-HPMA缀合物 DOTA共轭N-(2-羟丙基)甲基丙烯酰胺聚合物 |
154 |
h |
2024-12-19 |
| 83555 |
G3-cNGR肽缀合物 |
173 |
h |
2024-12-19 |
| 83556 |
DOTA-USMSN DOTA偶联介孔二氧化硅纳米颗粒 |
131 |
h |
2024-12-19 |
| 83557 |
Gd-DOTA-CC9 环肽CC9偶联Gd-DOTA |
189 |
h |
2024-12-19 |
| 83558 |
DOTA-尼妥珠单抗缀合物 DOTA-NIM |
108 |
h |
2024-12-19 |
| 83559 |
DOTA功能化杯[4]芳烃 DOTA-Calix[4]arenes |
128 |
h |
2024-12-19 |
| 83560 |
DOTA-Modified 2-Hydroxypropyl-β-Cyclodextrin/4-Sulfobutyl Ether-β-Cyclodextrin-Based Polyrotaxanes |
90 |
h |
2024-12-19 |
| 83561 |
CQDs-DOTA-Eu 铕-DOTA螯合物功能化碳量子点 |
194 |
h |
2024-12-19 |
| 83562 |
DOTA-曲普瑞林 DOTA-TRP |
127 |
h |
2024-12-19 |
| 83563 |
DOTA-Boron-ENPY 大环DOTA偶联16氨基酸的NPY衍生物 |
164 |
h |
2024-12-19 |
| 83564 |
DOTA-CDP1 DOTA功能化凯萨林菌素衍生肽 |
155 |
h |
2024-12-19 |
| 83565 |
Fe3O4@SiO2-APTES-DOTA-Teniposide 氧化铁@二氧化硅核壳纳米粒子偶联DOTA分子共轭替尼泊苷药物 |
211 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询